Switzerland: Food and Drugs Law

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Consultation Opened On Amendments To Pharmaceutical Pricing

Switzerland is moving ahead with the implementation of the Cost Containment Package 2: On 18 February 2026, the Federal Council opened the consultation on a third set of significant revisions...

Switzerland Healthcare

BK

Bär & Karrer

European Pet, Vet & Animal-health Sector Overview

The European pet, veterinary services and animal-health sector is a large, growing market driven by the "humanisation" of pets and associated rising pet ownership...

Switzerland Healthcare

GGI Global Alliance

Digital Agriculture: How Patents Help To Ensure Sustainable Food Security

The European Patent Office (EPO) has launched a series of initiatives to measure and encourage innovation in digital agriculture across the EU.

European Union IP

NG

Novagraaf Group

Swiss Therapeutic Products Act Revision: A Step Forward In Digitalization

At the beginning of September 2025, the Swiss Federal Council published the dispatch for the partial revision of the Therapeutic Products Act (TPA).

Switzerland Healthcare

BK

Bär & Karrer

Revision Des Heilmittelgesetzes (HMG): Erhöhte Medikationssicherheit Und Arzneimittel Für Neuartige Therapien

Switzerland Healthcare

BK

Bär & Karrer

A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight

Switzerland Accounting

BI

Buchanan Ingersoll & Rooney PC

Cost Containment Measures In Switzerland Regarding Pharmaceuticals: Pricing Models Under Current And New Law

Switzerland Healthcare

BK

Bär & Karrer

Swiss Federal Supreme Court Prohibits The Use Of Animal Species Names For Plant-Based Meat Substitutes

Switzerland Healthcare

LS

Lenz & Staehelin

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Life Sciences 2025

Switzerland Healthcare

BK

Bär & Karrer

Panel Discussion: Supply Chain Disputes

Switzerland Litigation

BK

Bär & Karrer

"Burek King" Fails Against "BURGER KING" – The Federal Administrative Court Confirms Risk Of Confusion

M

MME

Life Sciences 2024

Switzerland Healthcare

BK

Bär & Karrer

Switzerland And Laughing Gas Poisoning – A Legal Classification

Switzerland Healthcare

M

MME

A FinTech Legal: Blockchain & Cryptocurrencies Overview

Switzerland Technology

SW

Schellenberg Wittmer Ltd

Guidelines And Regulations To Provide Insights On Public Policies To Ensure AI's Beneficial Use As A Professional Tool - Switzerland

Switzerland Technology

SW

Schellenberg Wittmer Ltd

Open Banking And Open Finance In Switzerland

Switzerland Finance

RUGGLE Partner

FINMA Guidance 01/2026: New Requirements For The Custody Of Cryptobased Assets

Switzerland Technology

RUGGLE Partner

Switzerland: A Banking & Finance Overview - Current Status And Outlook For 2026

Switzerland Finance

BK

Bär & Karrer

Implications For Intellectual Property Rights Following Switzerland And India's New Free Trade Agreement

On March 10 2024, Switzerland – together with fellow European Free Trade Association members Liechtenstein, Norway and Iceland – signed the ‘Trade and Economic Partnership Agreement' with India.

LS

Lenz & Staehelin

Comprehensive Amendments To Swiss Food Law Regulations Effective February 2024

Starting February 2024, Swiss food manufacturers and retailers must comply with new standards following a comprehensive revision of Swiss food law.

European Union Healthcare

PL

Pestalozzi Attorneys at Law

Swiss Federal Supreme Court Rules That Recommended Resale Prices Of Pfizer Represent Unlawful Resale Price Maintenance

The Swiss Federal Supreme Court (FSC) has concluded that recommended resale prices issued by Pfizer Ltd. (Pfizer) constituted unlawful resale price maintenance...

Switzerland Anti-trust

BK

Bär & Karrer

Switzerland – The Food And Nutrition Innovation Center

Nestlé, the world's biggest food producer, has opened a new research center of package in Lausanne.

Switzerland Healthcare

Ga

Goldblum and Partners

Germany Is Going To Specify Safety Expectations For Reimbursable Digital Health Applications

Switzerland Healthcare

BK

Bär & Karrer

Regulatory Framework For CBD Products In Switzerland

Switzerland Healthcare

LL

Loyens & Loeff

Implementation Of Several Parts Of The Revised TPA And Pata As Well As Of The Therapeutic-Products-Ordinance-Package IV On 1 January 2019

Switzerland Healthcare

BK

Bär & Karrer

Marketing Under The New Swiss Tobacco Regulation

Switzerland Healthcare

GA

Global Advertising Lawyers Alliance (GALA)

Doping - Legalize It!

Switzerland Media & IT

RA

Rihm Attorneys

Reproductive Medicine - Permissibility And Limits In Switzerland

Switzerland Healthcare

MM

MLL Meyerlustenberger Lachenal Froriep Ltd

More Cocoa Powder For The Swiss? The Swiss View On The "Nutella Gap"

Switzerland Healthcare

Cv

CMS von Erlach Partners AG

Freispruch für das Doping!

Worldwide Media & IT

RA

Rihm Attorneys

New Regulations Regarding Drug Pricing

Switzerland Healthcare

BK

Bär & Karrer

Limited Swiss Pre-Approval Requirement For Pharmaceutical Advertising

Switzerland Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

More Cocoa Powder For The Swiss? The Swiss View On The "Nutella Gap"

Should Ferrero, the producer of Nutella, be hindered to produce a Swiss-style Nutella just for the Swiss market with more cocoa powder than the "normal" Nutella?

Switzerland Healthcare

Cv

CMS von Erlach Partners AG

Freispruch für das Doping!

Die heutige Dopingpolitik mit ihrer angeblichen Sorge um die Gesundheitsgefährdung von Spitzensportlern ist von Widersprüchen geprägt und möglicherweise verfassungswidrig.

Worldwide Media & IT

RA

Rihm Attorneys

New Regulations Regarding Drug Pricing

In its decision of 14 December 2015, the Swiss Federal Supreme Court had confirmed that the practice of the Federal Office of Public Health (FOPH) which, in the course of the regular triennial review, determines the prices of drugs...

Switzerland Healthcare

BK

Bär & Karrer

Limited Swiss Pre-Approval Requirement For Pharmaceutical Advertising

Switzerland is not part of the European Union and regulates advertising independently.

Switzerland Media & IT

GA

Global Advertising Lawyers Alliance (GALA)

Neue Regeln Für Die Festsetzung Der Medikamentenpreise

Switzerland Healthcare

BK

Bär & Karrer

Grundsatzurteil Und Verordnungsrevisionen Betreffend Überprüfung Von Arzneimittelpreisen

In einem Grundsatzentscheid vom 30. April 2015 hat das Bundesverwaltungsgericht entschieden, die bald fünfjährige Praxis des Bundesamts für Gesundheit (BAG)...

Switzerland Healthcare

BK

Bär & Karrer

Ordinary Revision Of The Therapeutic Products Act (2nd Stage): More Child-Friendly Medicines And Simplified Access To Medicines

Changes to the Therapeutic Products Act will improve public access to medicines and conditions for biomedical research and industry.

Switzerland Healthcare

MM

MLL Meyerlustenberger Lachenal Froriep Ltd

See more

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More